Correlation Between Dermata Therapeutics and GRI Bio
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and GRI Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and GRI Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and GRI Bio, you can compare the effects of market volatilities on Dermata Therapeutics and GRI Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of GRI Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and GRI Bio.
Diversification Opportunities for Dermata Therapeutics and GRI Bio
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dermata and GRI is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and GRI Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRI Bio and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with GRI Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRI Bio has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and GRI Bio go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and GRI Bio
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the GRI Bio. But the stock apears to be less risky and, when comparing its historical volatility, Dermata Therapeutics is 4.68 times less risky than GRI Bio. The stock trades about -0.17 of its potential returns per unit of risk. The GRI Bio is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 36.00 in GRI Bio on August 30, 2024 and sell it today you would earn a total of 40.00 from holding GRI Bio or generate 111.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.73% |
| Values | Daily Returns |
Dermata Therapeutics vs. GRI Bio
Performance |
| Timeline |
| Dermata Therapeutics |
| GRI Bio |
Dermata Therapeutics and GRI Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and GRI Bio
The main advantage of trading using opposite Dermata Therapeutics and GRI Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, GRI Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRI Bio will offset losses from the drop in GRI Bio's long position.| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
| GRI Bio vs. Agilent Technologies | GRI Bio vs. Equillium | GRI Bio vs. 23Andme Holding Co | GRI Bio vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |